| Patent | Date |
|---|
Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
App 20210317182 - Scholler; Nathalie ; et al. | 2021-10-14 |
Anti-TEM1 antibodies and uses thereof
Grant 11,078,285 - Scholler , et al. August 3, 2 | 2021-08-03 |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
Grant 11,041,012 - Scholler , et al. June 22, 2 | 2021-06-22 |
Isolated B7-H4 specific compositions and methods of use thereof
Grant 10,961,288 - Scholler , et al. March 30, 2 | 2021-03-30 |
Periostin Antibodies And Methods Of Using The Same
App 20210017288 - Abbott; Karen ; et al. | 2021-01-21 |
Mesothelin Vaccine For Ovarian Cancer Prevention
App 20200078455 - Scholler; Nathalie ; et al. | 2020-03-12 |
Isolated B7-h4 Specific Compositions And Methods Of Use Thereof
App 20200024314 - Scholler; Nathalie ; et al. | 2020-01-23 |
Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
App 20190330300 - Scholler; Nathalie ; et al. | 2019-10-31 |
Anti-tem1 Antibodies And Uses Thereof
App 20190194332 - Scholler; Nathalie ; et al. | 2019-06-27 |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
Grant 10,266,580 - Scholler , et al. | 2019-04-23 |
Isolated B7-H4 specific compositions and methods of use thereof
Grant 10,259,849 - Scholler , et al. | 2019-04-16 |
Anti-TEM1 antibodies and uses thereof
Grant 10,160,809 - Scholler , et al. Dec | 2018-12-25 |
Anti-mesothelin Antibodies And Uses Thereof
App 20180002439 - BATY; Daniel ; et al. | 2018-01-04 |
Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
App 20170342124 - Scholler; Nathalie ; et al. | 2017-11-30 |
Anti-tem1 Antibodies And Uses Thereof
App 20170281793 - SCHOLLER; Nathalie ; et al. | 2017-10-05 |
Isolated Anti-mesothelin Antibodies, Conjugates And Uses Thereof
App 20170267755 - Scholler; Nathalie | 2017-09-21 |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
Grant 9,708,384 - Scholler , et al. July 18, 2 | 2017-07-18 |
Anti-TEM1 antibodies and uses thereof
Grant 9,556,272 - Scholler , et al. January 31, 2 | 2017-01-31 |
Isolated B7-H4 specific compositions and methods of use thereof
Grant 9,422,351 - Scholler , et al. August 23, 2 | 2016-08-23 |
Isolated B7-h4 Specific Compositions And Methods Of Use Thereof
App 20160222119 - SCHOLLER; Nathalie ; et al. | 2016-08-04 |
Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates
Grant 9,345,785 - Law , et al. May 24, 2 | 2016-05-24 |
Isolated B7-H4 specific compositions and methods of use thereof
Grant 9,279,008 - Scholler , et al. March 8, 2 | 2016-03-08 |
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
Grant 9,272,002 - Powell, Jr. , et al. March 1, 2 | 2016-03-01 |
Isolated B7-h4 Specific Compositions And Methods Of Use Thereof
App 20140308259 - Scholler; Nathalie ; et al. | 2014-10-16 |
Fully Human, Anti-mesothelin Specific Chimeric Immune Receptor For Redirected Mesothelin-expressing Cell Targeting
App 20140301993 - Powell, JR.; Daniel J. ; et al. | 2014-10-09 |
Isolated B7-h4 Specific Compositions And Methods Of Use Thereof
App 20140294861 - Scholler; Nathalie ; et al. | 2014-10-02 |
Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
App 20140234348 - Scholler; Nathalie ; et al. | 2014-08-21 |
Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates
Grant 8,609,104 - Law , et al. December 17, 2 | 2013-12-17 |
Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
Grant 8,535,678 - Law , et al. September 17, 2 | 2013-09-17 |
Anti-tem1 Antibodies And Uses Thereof
App 20120294799 - Scholler; Nathalie ; et al. | 2012-11-22 |
Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
App 20120288512 - Law; Che-Leung ; et al. | 2012-11-15 |
Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates
App 20120251559 - Law; Che-Leung ; et al. | 2012-10-04 |
Methods and Compositions for Diagnosing Carcinomas
App 20110104675 - Scholler; Nathalie ; et al. | 2011-05-05 |
Vectors for expressing in vivo biotinylated recombinant proteins
Grant 7,795,411 - Scholler , et al. September 14, 2 | 2010-09-14 |
Anti-cd70 Antibody-drug Conjugates And Their Use For The Treatment Of Cancer And Immune Disorders
App 20100183636 - Law; Che-leung ; et al. | 2010-07-22 |
Treatment Of Renal Cell Carcinoma With Anti-cd70 Antibody-drug Conjugates
App 20100158910 - Law; Che-Leung ; et al. | 2010-06-24 |
Treatment Of B-cell Cancers With Anti-cd70 Antibody-drug Conjugates
App 20100150925 - Law; Che-Leung ; et al. | 2010-06-17 |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
Grant 7,662,387 - Law , et al. February 16, 2 | 2010-02-16 |
Methods Of Generation And Use Of In Vivo Biotinylated Recombinant Antibodies
App 20080085539 - Scholler; Nathalie ; et al. | 2008-04-10 |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
App 20060233794 - Law; Che-Leung ; et al. | 2006-10-19 |
Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion protein
App 20030219436 - Ledbetter, Jeffrey A. ; et al. | 2003-11-27 |
| 